Stocks · News reference

TransMedics Group shares are trading lower. The company appointed Fernando Araujo as CFO to replace Gerardo Hernandez and reaffirmed its FY26 sales guidance.

Sep 11, 2026, 2:41 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 10, 2026, 8:40 PMSEC EDGAR
8-K filing — TransMedics Group, Inc. (TMDX)
Filed: 2026-09-10 AccNo: 0001193125-26-387960 Size: 181 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
TMDX
BenzingaSep 10, 2026, 8:14 PMBenzinga Newsdesk
TransMedics Group Appoints Fernando Araujo CFO, Effective Sept. 21; Reaffirms FY26 Revenue Range $737M - $757M
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief Financial
TMDX
BenzingaSep 8, 2026, 2:14 PMBenzinga Newsdesk
TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target
TMDX